Wei He Selected Research

Therapeutics

3/2024	Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis.
2/2024	Watch-and-Wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma：a propensity score-matching comparative study.
1/2024	Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D.
12/2023	Multi-Stimuli-Responsive and Cell Membrane Camouflaged Aggregation-Induced Emission Nanogels for Precise Chemo-photothermal Synergistic Therapy of Tumors.
12/2023	A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease.
12/2023	Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy.
12/2023	The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study.
11/2023	UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance.
10/2023	Polymer-Initiating Caveolae-Mediated Endocytosis and GSH-Responsive MiR-34a Gene Delivery System for Enhanced Orthotopic Triple Negative Breast Cancer Therapy.
10/2023	Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei He Research Topics

Disease

335	Neoplasms (Cancer) 04/2024 - 11/2002
66	Inflammation (Inflammations) 04/2024 - 01/2006
53	Infections 03/2024 - 07/2003
52	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2005
50	Neoplasm Metastasis (Metastasis) 02/2024 - 06/2005
45	Osteonecrosis (Kienbock's Disease) 03/2024 - 10/2008
42	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 12/2007
38	Carcinoma (Carcinomatosis) 01/2023 - 11/2002
31	Pain (Aches) 09/2023 - 05/2006
29	Carcinogenesis 01/2024 - 01/2005
27	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 11/2010
24	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 10/2008
24	Wounds and Injuries (Trauma) 06/2023 - 07/2003
23	Hypoxia (Hypoxemia) 11/2023 - 01/2008
20	Renal Cell Carcinoma (Grawitz Tumor) 05/2024 - 05/2010
19	Osteoporosis 03/2024 - 05/2005
19	Dry Eye Syndromes (Dry Eye Syndrome) 02/2024 - 07/2020
19	Ischemia 01/2017 - 07/2003
18	Necrosis 07/2023 - 07/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 08/2009
16	Leukemia 04/2024 - 12/2004
16	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2010
16	Lung Neoplasms (Lung Cancer) 10/2022 - 08/2009
16	Body Weight (Weight, Body) 12/2021 - 07/2003
15	Hypertension (High Blood Pressure) 01/2024 - 12/2007
14	Lymphatic Metastasis 11/2023 - 06/2006
14	Esophageal Squamous Cell Carcinoma 11/2023 - 01/2009
14	Ischemic Stroke 04/2023 - 05/2013
13	Hemorrhage 03/2024 - 01/2015
13	Disease Progression 03/2024 - 10/2008
13	Colitis 10/2023 - 06/2006
13	Thrombosis (Thrombus) 08/2023 - 07/2003
13	Brain Ischemia (Cerebral Ischemia) 01/2023 - 11/2003
13	Type 2 Diabetes Mellitus (MODY) 11/2022 - 02/2007
13	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2002
12	COVID-19 01/2024 - 08/2020
11	Acute Lung Injury 04/2024 - 01/2016
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 04/2013
11	Hyperalgesia 01/2023 - 03/2017
10	Sepsis (Septicemia) 03/2024 - 08/2017
10	Rheumatoid Arthritis 09/2023 - 05/2006
10	Reperfusion Injury 01/2023 - 01/2004
10	Fibrosis (Cirrhosis) 12/2022 - 12/2010
10	Obesity 05/2022 - 08/2015
9	Glioma (Gliomas) 03/2024 - 05/2012
9	Bone Resorption 03/2024 - 11/2015
9	Critical Illness (Critically Ill) 10/2023 - 01/2007
9	Stomach Neoplasms (Stomach Cancer) 10/2023 - 08/2009
9	Diabetes Mellitus 01/2019 - 09/2012

Drug/Important Bio-Agent (IBA)

127	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2003
50	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2005
40	CytokinesIBA 03/2024 - 02/2004
34	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2012
28	Messenger RNA (mRNA)IBA 03/2024 - 07/2003
28	SteroidsIBA 10/2023 - 07/2009
26	LigandsIBA 01/2023 - 01/2006
25	Therapeutic UsesIBA 03/2024 - 05/2006
25	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 06/2003
23	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 06/2008
23	AntigensIBA 11/2023 - 08/2002
22	Long Noncoding RNAIBA 03/2024 - 01/2016
21	LipidsIBA 02/2024 - 07/2009
20	VaccinesIBA 03/2024 - 12/2003
20	EnzymesIBA 02/2024 - 11/2003
18	Hormones (Hormone)IBA 03/2024 - 09/2004
17	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 12/2008
16	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2010
15	Insulin (Novolin)FDA Link 11/2023 - 08/2007
15	Interleukin-6 (Interleukin 6)IBA 12/2022 - 06/2002
14	LipopolysaccharidesIBA 12/2023 - 07/2003
14	Immunoglobulin G (IgG)IBA 04/2023 - 12/2003
13	Liposomes (Liposome)IBA 08/2023 - 07/2015
13	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 08/2013
13	Small Interfering RNA (siRNA)IBA 12/2022 - 02/2009
12	AntibodiesIBA 10/2023 - 08/2002
12	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2006
11	RNA (Ribonucleic Acid)IBA 12/2023 - 06/2007
11	salicylhydroxamic acid (SHAM)IBA 12/2023 - 10/2004
11	Estrogen ReceptorsIBA 10/2023 - 10/2016
11	InterleukinsIBA 03/2023 - 01/2006
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 06/2002
10	Circular RNAIBA 11/2023 - 01/2021
10	Blood Glucose (Blood Sugar)IBA 10/2023 - 05/2009
10	Retinaldehyde (Retinal)IBA 01/2022 - 01/2015
9	AntioxidantsIBA 04/2024 - 11/2003
9	FlavonoidsIBA 03/2024 - 07/2009
9	Peptides (Polypeptides)IBA 11/2023 - 05/2005
9	Folic Acid (Vitamin M)FDA LinkGeneric 04/2023 - 10/2008
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 04/2008
9	Everolimus FDA Link 01/2023 - 01/2016
9	Indicators and Reagents (Reagents)IBA 01/2022 - 12/2011
9	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2015
9	Matrix Metalloproteinases (MMPs)IBA 06/2020 - 04/2013

Therapy/Procedure

170	Therapeutics 03/2024 - 02/2004
51	Drug Therapy (Chemotherapy) 01/2024 - 08/2009
30	Immunotherapy 05/2024 - 01/2005
21	Electroacupuncture 01/2023 - 12/2011
10	Radiotherapy 12/2023 - 08/2009
9	Aftercare (After-Treatment) 03/2024 - 05/2006
9	Hepatectomy 11/2023 - 07/2015